Informations générales (source: ClinicalTrials.gov)
Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin - OVAmiARN Study
Observational
ZIWIG (Voir sur ClinicalTrials)
mai 2022
avril 2026
16 septembre 2025
OVAmiARN is a multicentre, prospective, longitudinal, non-interventional, observational
study carried out in 8 obstetrics and gynecology departments in France; in order to
describe the evolution of salivary miRNA expression between the pre-operative and
post-therapy visits according to the type of mass. In time, the clinical application will
be to significantly reduce the time to diagnosis and improve the care pathway for ovarian
adnexal mass.
The study population consists of patients with an ovarian adnexal mass diagnosed by
clinical examination and imaging (pelvic ultrasound and/or MRI) and requiring surgical
management in routine care.
The patients concerned by the study will be managed without modification of the care
pathway, nor modification of the therapeutic indications, nor modification of the
diagnostic or follow-up examinations (imaging or biology) necessary according to the
context, which are carried out according to the recommendations of the HAS, CNGOF.
In this study, the management and follow-up of patients :
- Are not imposed by the study: the doctor remains free to make medical prescriptions
(treatments and examinations) and to determine the interval between consultation
visits,
- Are not modified in comparison with the usual follow-up, except for the performance
of the Collection of saliva
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT GUSTAVE ROUSSY | Alexandra LEARY | 25/05/2024 13:47:04 | Contacter | ||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| AP-HP - Hôpital Tenon | Sofiane Bendifallah, Dr | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Antoine Lacassagne - Nice - France | Marie Gosset, MD | Contact (sur clinicalTrials) | |||
| CH Bastia - 20600 - Bastia - France | Laetitia Elisabeth Rocca, Dr | Contact (sur clinicalTrials) | |||
| CH Niort - 79021 - Niort - France | Sandrine Richard, Dr | Contact (sur clinicalTrials) | |||
| CHRU Bretonneau-Tours - 37044 - Tours - France | Lobna Ouldamer, Pr | Contact (sur clinicalTrials) | |||
| CHU Angers - 49933 - Angers - France | Philippe Descamps, Pr | Contact (sur clinicalTrials) | |||
| CHU de Caen - 14000 - Caen - Calvados - France | Raffaèle Fauvet, Pr | Contact (sur clinicalTrials) | |||
| CHU Lyon Sud / Hospices Civils de Lyon - 69000 - Lyon - France | François Golfier, Pr | Contact (sur clinicalTrials) | |||
| CHU Rennes - 35000 - Rennes - France | Vincent Lavoué, Pr | Contact (sur clinicalTrials) | |||
| CHU Rouen, Hôpital de Bois-Guillaume - Rouen - France | Clotilde Hennetier, MD | Contact (sur clinicalTrials) | |||
| Clinique La sagesse - Rennes - France | Claire Marie Roger, MD | Contact (sur clinicalTrials) | |||
| Clinique Pasteur - Toulouse - France | Ludivine Genre, MD | Contact (sur clinicalTrials) | |||
Critères
Femme
Inclusion Criteria:
- Patient over 18 years of age,
- A patient with an ovarian adnexal mass diagnosed by clinical examination and imaging
and likely to be ovarian cancer, a borderline tumour or a benign cyst,
- Patient with an indication for surgery
- Patient has dated and signed the consent form,
- Patient affiliated to the healthcare system,
- Patient over 18 years of age,
- A patient with an ovarian adnexal mass diagnosed by clinical examination and imaging
and likely to be ovarian cancer, a borderline tumour or a benign cyst,
- Patient with an indication for surgery
- Patient has dated and signed the consent form,
- Patient affiliated to the healthcare system,
- Pregnant patient
- Patient infected with human immunodeficiency virus (HIV),
- Patient with significant difficulties in reading or writing the French language.
- Patient with another diagnosed cancer
- Patient with a history of cancer less than 5 years old